BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6617759)

  • 1. Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor.
    Jung-Testas I; Baulieu EE
    Exp Cell Res; 1983 Aug; 147(1):177-82. PubMed ID: 6617759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-steroid action in cultured L-929 mouse fibroblasts.
    Jung-Testas I; Baulieu EE
    J Steroid Biochem; 1984 Jan; 20(1):301-6. PubMed ID: 6708516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of steroid hormones and antihormones in cultured cells.
    Jung-Testas I; Baulieu EE
    Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chick oviduct glucocorticosteroid receptor. Specific binding of the synthetic steroid RU 486 and immunological studies with antibodies to chick oviduct progesterone receptor.
    Groyer A; Le Bouc Y; Joab I; Radanyi C; Renoir JM; Robel P; Baulieu EE
    Eur J Biochem; 1985 Jun; 149(2):445-51. PubMed ID: 3996417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486.
    Bourgeois S; Pfahl M; Baulieu EE
    EMBO J; 1984 Apr; 3(4):751-5. PubMed ID: 6327286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity binding and regulatory actions of dexamethasone-type I receptor complexes in mouse brain.
    Luttge WG; Davda MM; Rupp ME; Kang CG
    Endocrinology; 1989 Sep; 125(3):1194-203. PubMed ID: 2759022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RU 38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation.
    Moguilewsky M; Philibert D
    J Steroid Biochem; 1984 Jan; 20(1):271-6. PubMed ID: 6708512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU-26988--a new tool for the study of the mineralocorticoid receptor.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]cortivazol: a unique high affinity ligand for the glucocorticoid receptor.
    Schlechte JA; Simons SS; Lewis DA; Thompson EB
    Endocrinology; 1985 Oct; 117(4):1355-62. PubMed ID: 4029081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activation and DNA binding affinity of human lymphoid (CEM-C7) cytoplasmic receptors labeled with the antiglucocorticoid RU 38486.
    Schmidt TJ
    J Steroid Biochem; 1986 Apr; 24(4):853-63. PubMed ID: 2871233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of the anti-glucocorticosteroid effect of RU486 on the growth of mouse fibroblasts in culture by the immunosuppressor kf506]].
    Jung-Testas I; Delespierre B; Baulieu EE
    C R Acad Sci III; 1993 Dec; 316(12):1495-9. PubMed ID: 7522119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RU 38486: a potent antiglucocorticoid in vitro and in vivo.
    Gagne D; Pons M; Philibert D
    J Steroid Biochem; 1985 Sep; 23(3):247-51. PubMed ID: 2864478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic localization of glucocorticosteroid and progesterone binding sites in the human post-mortem brain.
    Sarrieau A; Dussaillant M; Agid F; Philibert D; Agid Y; Rostene W
    J Steroid Biochem; 1986 Nov; 25(5B):717-21. PubMed ID: 3807360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of antiglucocorticoid RU 486 with rat kidney glucocorticoid receptor.
    Kalimi MY; Agarwal MK
    Biochem Biophys Res Commun; 1988 May; 153(1):365-71. PubMed ID: 3377791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid receptors in WI-38 fibroblasts: characterization and changes with population doubling in culture.
    Kalimi M; Seifter S
    Biochim Biophys Acta; 1979 Mar; 583(3):352-9. PubMed ID: 444567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the relation between receptor binding affinity and antagonist efficacy of antiglucocorticoids.
    Gagne D; Pons M; Crastes de Paulet A
    J Steroid Biochem; 1986 Sep; 25(3):315-22. PubMed ID: 2877119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the interaction of RU 486 and ketoconazole with the second binding site of the glucocorticoid receptor.
    Svec F
    Endocrinology; 1988 Oct; 123(4):1902-6. PubMed ID: 3416819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of the anti-progestin RU-486 to rat ovary steroid receptors.
    Schreiber JR; Hsueh AJ; Baulieu EE
    Contraception; 1983 Jul; 28(1):77-85. PubMed ID: 6627946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of [3H]cortivazol to characterize glucocorticoid receptors in a dexamethasone-resistant human leukemic cell line.
    Schlechte JA; Schmidt TJ
    J Clin Endocrinol Metab; 1987 Mar; 64(3):441-6. PubMed ID: 2880860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid activity of 11 beta,17 beta-dihydroxy-21-methyl-17 alpha-pregna-1,4,6-trien-20-yn-3-one (RU-26988).
    Gomez-Sanchez EP; Gomez-Sanchez CE; Ferris MW
    J Steroid Biochem; 1983 Dec; 19(6):1819-22. PubMed ID: 6142979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.